ARScience Biotherapeutics appoints Gustavo Mahler as CEO
Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management
Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management
Report reveals growing confidence in AI-driven decision-making, but highlights persistent challenges in scaling digital investments and converting innovation into measurable business value
Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy
Samelisant will be the centerpiece of Suven’s scientific presence
MeRT becomes one of the few FDA-cleared neuromodulation therapies for PTSD, using EEG biomarkers and AI to personalize treatment for patients with treatment-resistant symptoms
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
We are building the bridge between complex molecular data and everyday clinical decisions
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
Subscribe To Our Newsletter & Stay Updated